| Healthy subjects (n = 30) | ESRD with targeted iPTH (n = 32) | ESRD with increased iPTH(n = 40) | P |
---|---|---|---|---|
Age (years) | 48.1 ± 11.6 | 58.2 ± 13.9 | 57.4 ± 15.0 | 0.06 |
Gender (Male, n) | 12(40.0%) | 12(37.5%) | 15(37.5%) | 0.54 |
Height (cm) | 152.8 ± 7.9 | 154.8 ± 23.1 | 156.5 ± 6.5 | 0.41 |
Weight (kg) | 53.6 ± 6.6 | 50.3 ± 3.2 | 53.3 ± 9.6 | 0.47 |
Heart rate (beats/min) | 71 ± 9 | 81 ± 12 | 78 ± 13 | 0.08 |
Duration of dialysis (M) | N/A | 12–132 | 9–228 | 0.06 |
Duration of renal insufficiency (M) | N/A | 12–156 | 12–228 | 0.06 |
Systolic BP | N/A | 136 ± 26 | 142 ± 20 | 0.34 |
Diastolic BP | N/A | 82 ± 13 | 89 ± 17 | 0.24 |
Causes of ESRD | Â | Â | Â | Â |
 Polycystic kidney disease (n, %) | N/A | 4(12.5%) | 6(15.0%) | N/A |
  Primary glomerular nephropathy (n, %) | N/A | 23(44.3%) | 29(55.8%) | N/A |
 Vasculitis (n, %) | N/A | 1(3.1%) | 3(7.5%) | N/A |
 Genitourinary tuberculosis (n, %) | N/A | 2(6.3%) | 4(10.0%) | N/A |